Two possibilities how to increase the efficacy of antidotal treatment of nerve agent poisonings

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 1, 2012, Pages 24-34

  Kassa, J ^a   Musilek, K ^a   Zdarova Karasova, J ^a   Kuca, K ^b   Bajgar, J ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Acetylcholinesterase; Antidotal treatment; Combination of oximes; Nerve agents; Oximes

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; CHEMICAL WARFARE AGENT; OBIDOXIME; ORGANOPHOSPHORUS COMPOUND; PRALIDOXIME; TABUN; TRIMEDOXIME;

ACUTE TOXICITY; ARTIFICIAL NEURAL NETWORK; DRUG DESIGN; DRUG EFFICACY; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL RESEARCH; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; PREDICTION; REVIEW;

ANTIDOTES; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; HUMANS; OXIMES; TREATMENT OUTCOME;

EID: 84855830624     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712798869011     Document Type: Review

References (56)

1. Bajgar, J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem., 2004, 38, 151-216.
2. Tu, A.T. Chemical Terrorism: Horrors in Tokyo Subway and Matsumoto City, Alaken Inc., 2002.
3. Lotti, M. Organophosphorus compounds. In: Experimental and Clinical Neurotoxicology, Spencer, P.S.; Schaumburg, H.H., Eds.; Oxford University Press: New York, 2000; pp. 898-925.
4. Marrs, T.C. Organophosphate poisoning. Pharmacol. Ther., 1993, 58, 51-66.
5. Dawson, R.M. Review of oximes available for the treatment of nerve agent poisoning. J. Appl. Toxicol., 1994, 14, 317-31.
6. Taylor, P. Anticholinesterase agents. In: The Pharmacological Basis of Therapeustics, Hardman, J.G., Limbird, L.E., Eds.; McGraw: New York, 1996; pp. 161-76.
7. Shih, T.-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch. Toxicol., 1993, 67, 637-46.
8. Kassa, J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol., 2002, 40, 803-16.
9. Rousseaux, C.G.; Dua, A.K. Pharmacology of HI-6, an H-series oxime. Can. J. Physiol. Pharmacol., 1989, 67, 1183-9.
10. Lundy, P.M.; Raveh, L.; Amitai, G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev., 2006, 25, 231-43.
11. Kuca, K.; Cabal, J.; Jun, D.; Kassa, J.; Bartosova, L.; Kunesova, G.; Dohnal, V. Strategy for the development of new acetylcholinesterase reactivators-antidotes used for treatment of nerve agent poisonings. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2005, 149, 429-31.
12. Dohnal, V.; Kuca, K.; Jun, D. J. Prediction of a new broadspectrum reactivator capable of reactivating acetycholinesterase inhibited by nerve agents. J. Appl. Biomed., 2005, 3, 139-45.
13. Musilek, K., Jun, D., Cabal, J., Kassa, J., Gunn-Moore, F., Kuca, K. Design of a potent reactivators of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide. J. Med. Chem., 2007, 5514-8.
14. Musilek, K.; Kuca, K.; Jun, D.; Dolezal, M. Progress in synthesis of new acetylcholinesterase reactivators during the period 1990-2004. Curr. Org. Chem., 2007, 11, 229-38.
15. Kuca K, Jun D, Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini-Rev. Med. Chem., 2006, 6, 109-20.
16. Wiesner, J.; Kriz, Z.; Kuca, K.; Jun, D.; Koca, J. Computer modeling and simulation-new technologies in development of means against combat chemical substances. Voj. zdrav. Listy, 2005, 74, 165-71 (in Czech).
17. Kuca, K.; Kassa, J. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)-butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzym. Inhib. Med. Chem., 2003, 18(6), 529-35.
18. Kassa J.; Kuca, K.; Bartosova, L.; Kunesova, G. The development of new structural analogues of oximes for the antidotal treatment of poisonings by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr. Org. Chem., 2007, 11, 267-83.
19. Tallarida, R.; Murray, R. Manual of Pharmacological Calculation with Computer Programs, New York: Springer-Verlag, 1987.
20. Ellman, G.L.; Courtney, D.K.; Andres, V. Jr.; Feartherstone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 1961, 7, 88-93.
21. Clement, J.G.; Hansen, A.S.; Boulet, C.A. Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch. Toxicol., 1992, 66, 216-9.
22. Kuca, K.; Patocka, J.; Cabal, J. Reactivation of organophosphate inhibited acetylcholinesterase activity by α, ω-bis-(4-hydroxyiminomethylpyridinium) alkanes in vitro. J. Appl Biomed., 2003, 1, 207-11.
23. Musilek, K.; Holas, O.; Kuca, K.; Jun, D.; Dohnal, V.; Opletalova, V.; Dolezal, M. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker-synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem Lett., 2007, 17, 3172-6.
24. Bajgar, J.; Fusek, J.; Kuca, K.; Bartosova, L.; Jun, D. Treatment of organophosphate intoxication using cholinesterase reactivators: Facts and fiction. Mini-Rev. Med. Chem., 2007, 7, 461-6.
25. Tattersall, J.E. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br. J. Pharmacol., 1993, 108, 1006-15.
26. Kenley, R.A.; Howd, R.A.; Mosher, C.W.; Winterle, J.S. Nonquaternary cholinesterase reactivators. Dialkyminoalkyl thioesters of alpha-ketothiohydroximic acids as reactivators of diisopropyl phosphorofluoridate inhibited acetylcholinesterase. J. Med. Chem., 1981, 24, 1124-33.
27. Herrador, M.M.; Saenz de Buruaga, J.; Suarez, M.D. Reactivators of organophosphorus-inhibited acetylcholinesterase. 1. Imidazole oxime derivatives. J. Med. Chem., 1985, 28, 146-9.
28. Kassa, J.; Karasova, J.; Musilek, K.; Kuca, K. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology, 2008, 243, 311-6.
29. Musilek, K.; Holas, O.; Jun, D.; Dohnal, V.; Gunn-Moore, F.; Opletalova, V.; Dolezal, M.; Kuca, K. Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker-Preparation and reactivation of tabun and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem., 2007, 15, 6733-41.
30. Musilek, K.; Holas, O.; Kuca, K.; Jun, D.; Dohnal, V.; Opletalova, V.; Dolezal, M. Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun-and paraoxon-inhibited acetylcholinesterase. J. Enzym. Inhib. Med. Chem., 2008, 23(1), 70-6.
31. Kovarik, Z.; Lucic Vrdoljak, A.; Berend, S.; Catalinic, M.; Kuca, K.; Musilek, K.; Radic, B. 2009. Evaluation of oxime K203 as antidote in tabun poisoning. Arh. Hig. Rada Toksikol., 2009, 60, 19-26.
32. Cabal, J.; Kuca, K.; Kassa, J. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol. Toxicol., 2004, 95, 81-6.
33. Worek, F.; Kirchner, T.; Bäker, M.; Szinicz, L. Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch. Toxicol., 1996, 70, 497-503.
34. Marrs, T.C.; Rice, P.; Vale, J.A. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol. Rev., 2006, 25, 297-323.
35. Maxwell, D.M.; Koplovitz, I.; Worek, F.; Sweeney, R.E. A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicol. Appl. Pharmacol., 2008, 231, 157-64.
36. Jokanovic, M.; Maksimovic, M. A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Arch. Toxicol., 1995, 70, 119-23.
37. Petroianu, G.A.; Nurulain, S.M.; Nagelkerke, N.; Shafiullah, M.; Kassa, J.; Kuca, K. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J. Appl. Toxicol., 2007, 27, 453-7.
38. Kassa, J.; Cabal, J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology, 1999, 132, 111-8.
39. Kassa, J.; Cabal, J. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexylmethylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol. Toxicol., 1999, 84, 41-5.
40. Kassa, J.; Zdarova Karasova, J.; Musilek, K.; Kuca, K. A comparison of reactivating and therapeutic efficacy of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice. Toxicol. Mech. Meth., 2009, 19, 346-50.
41. Kassa, J.; Zdarova Karasova, J.; Caisberger, F.; Bajgar, J. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice. Toxicol. Mech. Meth., 2009, 19, 547-51.
42. Clement, J.G.; Shiloff, J.D.; Gennings, Ch. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice. Arch. Toxicol., 1987, 61, 70-5.
43. Kovacevic, V.; Maksimovic, M.; Pantelic, D.; Vojvodic, V.; Binenfeld, Z. Protective and reactivating effects of HI-6 PAM-2 mixture in rats poisoned with nerve chemical warfare agents. Acta Pharm. Jugoslav., 1989, 39, 161-5.
44. Kovacevic, V.; Maksimovic, M.; Deljac, V.; Binenfeld, Z. Protective effects of mixture of oximes in poisoning by nerve chemical warfare agents. Acta Pharm. Jugoslav., 1991, 41, 75-8.
45. Maksimovic, M.; Kovacevic, V. Protective and reactivating effects of HI-6-toxogonin mixture in rats and guinea-pigs poisoned by nerve agents. Acta Pharm. Jugoslav., 1989, 39, 27-33.
46. Luo, C.Y.; Tong, M.; Chilukuri, N.; Brecht, K.; Maxwell, D.M.; Saxena, A. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea-pig and human acetylcholinesterases by oximes. Biochemistry, 2007, 48, 11771-9.
47. Herkert, N.M.; Lallement, G.; Clarencon, D.; Thiermann, H.; Worek, F. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity. Toxicology, 2009, 258, 79-83.
48. Kuca, K.; Musilek, K.; Jun, D.; Pohanka, M.; Zdarova Karasova, J.; Novotny, L.; Musilova, L. Could oxime HI-6 really be considered as “broad-spectrum” antidote? J. Appl. Biomed., 2009, 7, 143-9.
49. Kovarik, Z.; Calic, M.; Sinko, G.; Bosak, A.; Berend, S.; Vrdoljak, A.; Radic, B. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem-Biol. Interact., 2008, 175, 173-9.
50. Jokanovic, M.; Prostran, M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr. Med. Chem., 2009, 16, 2177-88.
51. Kassa, J.; Zdarova Karasova, J.; Pavlikova, R.; Misik, J.; Caisberger, F.; Bajgar, J. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice. J. Appl. Toxicol., 2010, 30, 120-4.
52. Worek, F.; Aurbek, N.; Thiermann, H. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. J. Appl. Toxicol., 2007, 27, 582-8.
53. Kim, T.-H.; Kuca, K.; Jun, D.; Jung, Y-S. Design and synthesis of new bis-pyridinium oxime reactivators for acetylcholinesterase inhibited by organophosphorous nerve agents. Bioorg. Med. Chem. Lett., 2005, 15, 2914-7.
54. Chennamaneni, S.R.; Vobalaboina, V.; Garlapati, A. Quaternary salts of 4,3' and 4,4' bis-pyridinium monoximes. Synthesis and biological activity. Bioorg. Med. Chem. Lett., 2005, 15, 3076-80.
55. Yang, G.Y.; Yoon, J.H.; Seong, C.M.; Park, N.S.; Jung, Y.S. Synthesis of bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophos-phate nerve agents. Bull. Korean Chem. Soc., 2003, 24(9), 1368-70.
56. Pang, Y.P.; Kollmeyer, T.M.; Hong, F.; Lee, J.C.; Hammond, P.J.; Haugabouk, S.P.; Brimijoin, S. Rational design of alkylene-linked bis-pyridiniumaldoxime as improved acetylcholinesterase reactivators. Chem. Biol., 2003, 10(6), 491-502.